drugset / Trial / NCT03567941

To Evaluate the Relative Abuse Potential of Hydrocodone Bitartrate and Acetaminophen

NCT03567941

Phase 1 Completed 32 enrolled Sun Pharma Advanced Research Company Limited
RandomizedCrossoverSingle-blindTreatment

Summary

Evaluation of abuse potential in recreational abusers of Hydrocodone Bitartrate and Acetaminophen versus NORCO®.

Timeline

Start
2017-12-29
Primary completion
2018-10-31
Completion
2018-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrocodone Unknown 60 mg Oral
Background Acetaminophen Small molecule 1950 mg Oral

Indications

No indication recorded.